13 Einträge gefunden

1. Posttransplant cyclophosphamide versus antithymocyte globulin in patients with acute lymphoblastic leukemia treated with allogeneic hematopoietic cell transplantation from matched unrelated donors: A study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

   1. Giebel, Sebastian
   2. Labopin, Myriam
   3. Salmenniemi, Urpu
   4. Socié, Gerard
   5. Bondarenko, Sergey
   6. Blaise, Didier
   7. Kröger, Nicolaus

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Correction: Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT

   1. Nagler, Arnon
   2. Ngoya, Maud
   3. Galimard, Jacques-Emmanuel
   4. Labopin, Myriam
   5. Kröger, Nicolaus
   6. Socié, Gerard
   7. Gedde-Dahl, Tobias

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Measurable residual disease, FLT3-ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1-mutated acute myeloid leukemia

   1. Al Hamed, Rama
   2. Labopin, Myriam
   3. Daguindau, Etienne
   4. Niittyvuopio, Riitta
   5. Huynh, Anne
   6. Socié, Gerard
   7. Srour, Micha

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT

   1. Nagler, Arnon
   2. Ngoya, Maud
   3. Galimard, Jacques-Emmanuel
   4. Labopin, Myriam
   5. Kröger, Nicolaus
   6. Socié, Gerard
   7. Gedde-Dahl, Tobias

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Posttransplant cyclophosphamide-based anti-graft-vs-host disease prophylaxis in patients with acute lymphoblastic leukemia treated in complete remission with allogeneic hematopoietic cell transplantation from human leukocyte antigen-mismatched unrelated donors versus haploidentical donors: A study on behalf of the ALWP of the EBMT

   1. Nagler, Arnon
   2. Labopin, Myriam
   3. Arat, Mutlu
   4. Reményi, Péter
   5. Koc, Yener
   6. Blaise, Didier
   7. Angelucci, Emanuele

   2022 - Forschungsinformationssystem des UKE
6. Comparable outcomes of haploidentical transplant with TBF conditioning versus matched unrelated donor with fludarabine/busulfan conditioning for acute myeloid leukemia

   1. Bazarbachi, Ali
   2. Labopin, Myriam
   3. Blaise, Didier
   4. Forcade, Edouard
   5. Socié, Gerard
   6. Berceanu, Ana
   7. Angelucci, Emanuele

   2021 - Forschungsinformationssystem des UKE
7. Allogeneic stem cell transplant in patients with acute myeloid leukemia and karnofsky performance status score less than or equal to 80%: A study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation (EBMT)

   1. Saraceni, Francesco
   2. Labopin, Myriam
   3. Forcade, Edouard
   4. Kröger, Nicolaus
   5. Socié, Gerard
   6. Niittyvuopio, Riitta
   7. Cornelissen, Jan J

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
8. Cytogenetic risk score maintains its prognostic significance in AML patients with detectable measurable residual disease undergoing transplantation in remission: On behalf of the acute leukemia working party of the European society for blood and marrow transplantation

   1. Nagler, Arnon
   2. Labopin, Myriam
   3. Canaani, Jonathan
   4. Niittyvuopio, Riitta
   5. Socié, Gerard
   6. Kröger, Nicolaus
   7. Itäla-Remes, Maija

   2020 - Forschungsinformationssystem des UKE - frei zugänglich
9. Graft-versus-host disease and graft-versus-leukaemia effects in secondary acute myeloid leukaemia: a retrospective, multicentre registry analysis from the Acute Leukaemia Working Party of the EBMT

   1. Baron, Frédéric
   2. Labopin, Myriam
   3. Savani, Bipin N
   4. Beohou, Eric
   5. Niederwieser, Dietger
   6. Eder, Matthias
   7. Potter, Victoria

   2020 - Forschungsinformationssystem des UKE
10. Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission:on behalf of the ALWP of the EBMT

    1. Shem-Tov, Noga
    2. Peczynski, Christophe
    3. Labopin, Myriam
    4. Itälä-Remes, Maija
    5. Blaise, Didier
    6. Labussière-Wallet, Hélène
    7. Socié, Gerard

    2020 - Forschungsinformationssystem des UKE
11. Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT

    1. Pavlů, Jiří
    2. Labopin, Myriam
    3. Niittyvuopio, Riitta
    4. Socié, Gerard
    5. Yakoub-Agha, Ibrahim
    6. Wu, Depei
    7. Remenyi, Peter

    2019 - Forschungsinformationssystem des UKE - frei zugänglich
12. CMV serostatus still has an important prognostic impact in de novo acute leukemia patients after allogeneic stem cell Transplantation: a report from the Acute Leukemia Working Party of EBMT

    1. Schmidt-Hieber, Martin
    2. Labopin, Myriam
    3. Beelen, Dietrich
    4. Volin, Liisa
    5. Ehninger, Gerhard
    6. Finke, Jürgen
    7. Socié, Gerard

    2013 - Forschungsinformationssystem des UKE
13. Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation.

    1. Schmid, Christoph
    2. Labopin, Myriam
    3. Nagler, Arnon
    4. Niederwieser, Dietger
    5. Castagna, Luca
    6. Tabrizi, Reza
    7. Stadler, Michael

    2012 - Forschungsinformationssystem des UKE